ABM Stock Price Decreases 12% Since Reporting Q2 Earnings Miss — Negative
ABM Zacks Investment Research — June 16, 2025ABM posts mixed second-quarter fiscal 2025 results as earnings fall short of estimates but revenues beat, with segment growth led by aviation and tech solutions.

Carlyle Announces Partnership With Citigroup on Asset-Backed Lending — Positive
C CG Zacks Investment Research — June 16, 2025CG is set to collaborate with C to expand fintech-focused asset-backed finance through a new strategic alliance.

C4 Therapeutics: An Entry Point If There's Ever Going To Be One — Positive
CCCC Seeking Alpha — June 16, 2025CCCC's valuation is unjustifiably low, trading at half its liquidity despite a promising pipeline and no imminent cash crisis. Lead candidate cemsidomide shows encouraging early efficacy and tolerability in heavily pretreated multiple myeloma patients, with key data readouts expected in Q3 2025. Cost controls and restructuring have extended CCCC's cash runway into 2027, reducing dilution risk and supporting ongoing development and partnerships.

3 Reasons Growth Investors Will Love Stantec (STN) — Positive
STN Zacks Investment Research — June 16, 2025Stantec (STN) could produce exceptional returns because of its solid growth attributes.

3 Reasons Growth Investors Will Love New Jersey Resources (NJR) — Positive
NJR Zacks Investment Research — June 16, 2025New Jersey Resources (NJR) could produce exceptional returns because of its solid growth attributes.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Quipt Home Medical Corp. - QIPT — Neutral
QIPT Accesswire — June 16, 2025NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Quipt Home Medical Corp. ("Quipt" or the "Company") (NASDAQ:QIPT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

Class Action Filed Against Rocket Pharmaceuticals, Inc. (RCKT) Over Securities Violations - Contact Levi & Korsinsky Today — Neutral
RCKT Accesswire — June 16, 2025NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rocket-pharmaceuticals-inc-lawsuit-submission-form?prid=153345&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq.

Permian Resources: The Growth Story Continues Right Through Market Uncertainty — Positive
PR Seeking Alpha — June 16, 2025Permian Resources continues to deliver rare growth through strategic, accretive acquisitions. Management's disciplined approach—favoring multiple small, value-accretive deals over large, costly ones—minimizes risk and maximizes upside. The company boasts top-tier acreage and a fortress balance sheet.

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN — Neutral
OGN Accesswire — June 16, 2025NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / WHY: New York, N.Y., June 16, 2025.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Petco Health And Wellness Company, Inc. - WOOF — Neutral
WOOF Accesswire — June 16, 2025NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Petco Health and Wellness Company, Inc. ("Petco" or the "Company") (NASDAQ:WOOF). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.

Dan Ives, Wedbush Securities, joins CNBC's Dom Chu on ‘Halftime Report' to discuss his new AI revolution ETF, the top holdings and how it stands out from the competition.

Lost Money on Rocket Companies, Inc. (RKT)? Contact Levi & Korsinsky Before July 8, 2025 to Join Class Action — Neutral
RKT Accesswire — June 16, 2025NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Rocket Companies, Inc. (NYSE:RKT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://www.zlk.com/pslra-1/rocket-companies-inc-loss-submission-form?prid=153344&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq.

SkyWater Banks on ThermaView Platform to Revive Wafer Services Growth — Positive
SKYT Zacks Investment Research — June 16, 2025SKYT rebounds with a 70% jump in Wafer Services revenues as its ThermaView platform gains rapid traction in defense.

SKYT vs. MRVL: Which Semiconductor Stock is the Better Investment? — Positive
MRVL SKYT Zacks Investment Research — June 16, 2025SkyWater Technology's quantum push, Fab 25 deal and lean valuation stack up strongly against Marvell Technology's AI-fueled momentum.

EchoStar soars 50% after report Trump urged EchoStar, FCC chair to reach deal on licenses — Positive
SATS Reuters — June 16, 2025Shares of EchoStar rose as much as 50% on Monday following a late Friday Bloomberg report that U.S. President Donald Trump urged EchoStar Chairman Charlie Ergen and Federal Communications Commission Chair Brendan Carr to reach a deal over the fate of the company's wireless spectrum licenses.

ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Vestis Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – VSTS — Neutral
VSTS GlobeNewsWire — June 16, 2025NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Vestis Corporation (NYSE: VSTS) between May 2, 2024 and May 6, 2025, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 8, 2025.

Novo Nordisk Stock Rises 6% in a Week: What Should Investors Do? — Positive
NVO Zacks Investment Research — June 16, 2025NVO jumps nearly 6% in a week on amycretin pipeline boost and hedge fund interest, but competition looms large.

Levi & Korsinsky Notifies Iovance Biotherapeutics, Inc. (IOVA) Shareholders of Class Action Lawsuit and July 14, 2025 Deadline — Neutral
IOVA Accesswire — June 16, 2025NEW YORK, NY / ACCESS Newswire / June 16, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=153343&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq.

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Gilead Sciences, Inc. - GILD — Neutral
GILD Accesswire — June 16, 2025NEW YORK CITY, NY / ACCESS Newswire / June 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Gilead Sciences, Inc. ("Gilead" or the "Company") (NASDAQ:GILD). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
